Global Heart Failure Drugs Market Growth 2022-2028
As the global economy mends, the 2021 growth of Heart Failure Drugs will have significant change from previous year. According to our latest study, the global Heart Failure Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Heart Failure Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Heart Failure Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Heart Failure Drugs market, reaching US$ million by the year 2028. As for the Europe Heart Failure Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Heart Failure Drugs players cover Novartis, Pfizer, AstraZeneca, and Hikma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Heart Failure Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
ACEI
Angiotensin II Receptor Blockers
ARNIs
Beta Blockers
Aldosterone Antagonists
Diuretics
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Reduced Ejection Fraction
Preserved Ejection Fraction
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novartis
Pfizer
AstraZeneca
Hikma
Teva
Cipla
Merck & Co.
Amgen
Roche
Sun Pharma
Mylan
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Heart Failure Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Heart Failure Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Heart Failure Drugs by Country/Region, 2017, 2022 & 2028
2.2 Heart Failure Drugs Segment by Type
2.2.1 ACEI
2.2.2 Angiotensin II Receptor Blockers
2.2.3 ARNIs
2.2.4 Beta Blockers
2.2.5 Aldosterone Antagonists
2.2.6 Diuretics
2.3 Heart Failure Drugs Sales by Type
2.3.1 Global Heart Failure Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Heart Failure Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Heart Failure Drugs Sale Price by Type (2017-2022)
2.4 Heart Failure Drugs Segment by Application
2.4.1 Reduced Ejection Fraction
2.4.2 Preserved Ejection Fraction
2.5 Heart Failure Drugs Sales by Application
2.5.1 Global Heart Failure Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Heart Failure Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Heart Failure Drugs Sale Price by Application (2017-2022)
3 Global Heart Failure Drugs by Company
3.1 Global Heart Failure Drugs Breakdown Data by Company
3.1.1 Global Heart Failure Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Heart Failure Drugs Sales Market Share by Company (2020-2022)
3.2 Global Heart Failure Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Heart Failure Drugs Revenue by Company (2020-2022)
3.2.2 Global Heart Failure Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Heart Failure Drugs Sale Price by Company
3.4 Key Manufacturers Heart Failure Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Heart Failure Drugs Product Location Distribution
3.4.2 Players Heart Failure Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Heart Failure Drugs by Geographic Region
4.1 World Historic Heart Failure Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Heart Failure Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Heart Failure Drugs Annual Revenue by Geographic Region
4.2 World Historic Heart Failure Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Heart Failure Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Heart Failure Drugs Annual Revenue by Country/Region
4.3 Americas Heart Failure Drugs Sales Growth
4.4 APAC Heart Failure Drugs Sales Growth
4.5 Europe Heart Failure Drugs Sales Growth
4.6 Middle East & Africa Heart Failure Drugs Sales Growth
5 Americas
5.1 Americas Heart Failure Drugs Sales by Country
5.1.1 Americas Heart Failure Drugs Sales by Country (2017-2022)
5.1.2 Americas Heart Failure Drugs Revenue by Country (2017-2022)
5.2 Americas Heart Failure Drugs Sales by Type
5.3 Americas Heart Failure Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Heart Failure Drugs Sales by Region
6.1.1 APAC Heart Failure Drugs Sales by Region (2017-2022)
6.1.2 APAC Heart Failure Drugs Revenue by Region (2017-2022)
6.2 APAC Heart Failure Drugs Sales by Type
6.3 APAC Heart Failure Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Heart Failure Drugs by Country
7.1.1 Europe Heart Failure Drugs Sales by Country (2017-2022)
7.1.2 Europe Heart Failure Drugs Revenue by Country (2017-2022)
7.2 Europe Heart Failure Drugs Sales by Type
7.3 Europe Heart Failure Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Heart Failure Drugs by Country
8.1.1 Middle East & Africa Heart Failure Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Heart Failure Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Heart Failure Drugs Sales by Type
8.3 Middle East & Africa Heart Failure Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Heart Failure Drugs
10.3 Manufacturing Process Analysis of Heart Failure Drugs
10.4 Industry Chain Structure of Heart Failure Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Heart Failure Drugs Distributors
11.3 Heart Failure Drugs Customer
12 World Forecast Review for Heart Failure Drugs by Geographic Region
12.1 Global Heart Failure Drugs Market Size Forecast by Region
12.1.1 Global Heart Failure Drugs Forecast by Region (2023-2028)
12.1.2 Global Heart Failure Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Heart Failure Drugs Forecast by Type
12.7 Global Heart Failure Drugs Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Heart Failure Drugs Product Offered
13.1.3 Novartis Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Heart Failure Drugs Product Offered
13.2.3 Pfizer Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca Heart Failure Drugs Product Offered
13.3.3 AstraZeneca Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 Hikma
13.4.1 Hikma Company Information
13.4.2 Hikma Heart Failure Drugs Product Offered
13.4.3 Hikma Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Hikma Main Business Overview
13.4.5 Hikma Latest Developments
13.5 Teva
13.5.1 Teva Company Information
13.5.2 Teva Heart Failure Drugs Product Offered
13.5.3 Teva Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Teva Main Business Overview
13.5.5 Teva Latest Developments
13.6 Cipla
13.6.1 Cipla Company Information
13.6.2 Cipla Heart Failure Drugs Product Offered
13.6.3 Cipla Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Cipla Main Business Overview
13.6.5 Cipla Latest Developments
13.7 Merck & Co.
13.7.1 Merck & Co. Company Information
13.7.2 Merck & Co. Heart Failure Drugs Product Offered
13.7.3 Merck & Co. Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Merck & Co. Main Business Overview
13.7.5 Merck & Co. Latest Developments
13.8 Amgen
13.8.1 Amgen Company Information
13.8.2 Amgen Heart Failure Drugs Product Offered
13.8.3 Amgen Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Amgen Main Business Overview
13.8.5 Amgen Latest Developments
13.9 Roche
13.9.1 Roche Company Information
13.9.2 Roche Heart Failure Drugs Product Offered
13.9.3 Roche Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Roche Main Business Overview
13.9.5 Roche Latest Developments
13.10 Sun Pharma
13.10.1 Sun Pharma Company Information
13.10.2 Sun Pharma Heart Failure Drugs Product Offered
13.10.3 Sun Pharma Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Sun Pharma Main Business Overview
13.10.5 Sun Pharma Latest Developments
13.11 Mylan
13.11.1 Mylan Company Information
13.11.2 Mylan Heart Failure Drugs Product Offered
13.11.3 Mylan Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Mylan Main Business Overview
13.11.5 Mylan Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Heart Failure Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Heart Failure Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of ACEI
Table 4. Major Players of Angiotensin II Receptor Blockers
Table 5. Major Players of ARNIs
Table 6. Major Players of Beta Blockers
Table 7. Major Players of Aldosterone Antagonists
Table 8. Major Players of Diuretics
Table 9. Global Heart Failure Drugs Sales by Type (2017-2022) & (MT)
Table 10. Global Heart Failure Drugs Sales Market Share by Type (2017-2022)
Table 11. Global Heart Failure Drugs Revenue by Type (2017-2022) & ($ million)
Table 12. Global Heart Failure Drugs Revenue Market Share by Type (2017-2022)
Table 13. Global Heart Failure Drugs Sale Price by Type (2017-2022) & (USD/MT)
Table 14. Global Heart Failure Drugs Sales by Application (2017-2022) & (MT)
Table 15. Global Heart Failure Drugs Sales Market Share by Application (2017-2022)
Table 16. Global Heart Failure Drugs Revenue by Application (2017-2022)
Table 17. Global Heart Failure Drugs Revenue Market Share by Application (2017-2022)
Table 18. Global Heart Failure Drugs Sale Price by Application (2017-2022) & (USD/MT)
Table 19. Global Heart Failure Drugs Sales by Company (2020-2022) & (MT)
Table 20. Global Heart Failure Drugs Sales Market Share by Company (2020-2022)
Table 21. Global Heart Failure Drugs Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Heart Failure Drugs Revenue Market Share by Company (2020-2022)
Table 23. Global Heart Failure Drugs Sale Price by Company (2020-2022) & (USD/MT)
Table 24. Key Manufacturers Heart Failure Drugs Producing Area Distribution and Sales Area
Table 25. Players Heart Failure Drugs Products Offered
Table 26. Heart Failure Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Heart Failure Drugs Sales by Geographic Region (2017-2022) & (MT)
Table 30. Global Heart Failure Drugs Sales Market Share Geographic Region (2017-2022)
Table 31. Global Heart Failure Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Heart Failure Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Heart Failure Drugs Sales by Country/Region (2017-2022) & (MT)
Table 34. Global Heart Failure Drugs Sales Market Share by Country/Region (2017-2022)
Table 35. Global Heart Failure Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Heart Failure Drugs Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Heart Failure Drugs Sales by Country (2017-2022) & (MT)
Table 38. Americas Heart Failure Drugs Sales Market Share by Country (2017-2022)
Table 39. Americas Heart Failure Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Heart Failure Drugs Revenue Market Share by Country (2017-2022)
Table 41. Americas Heart Failure Drugs Sales by Type (2017-2022) & (MT)
Table 42. Americas Heart Failure Drugs Sales Market Share by Type (2017-2022)
Table 43. Americas Heart Failure Drugs Sales by Application (2017-2022) & (MT)
Table 44. Americas Heart Failure Drugs Sales Market Share by Application (2017-2022)
Table 45. APAC Heart Failure Drugs Sales by Region (2017-2022) & (MT)
Table 46. APAC Heart Failure Drugs Sales Market Share by Region (2017-2022)
Table 47. APAC Heart Failure Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Heart Failure Drugs Revenue Market Share by Region (2017-2022)
Table 49. APAC Heart Failure Drugs Sales by Type (2017-2022) & (MT)
Table 50. APAC Heart Failure Drugs Sales Market Share by Type (2017-2022)
Table 51. APAC Heart Failure Drugs Sales by Application (2017-2022) & (MT)
Table 52. APAC Heart Failure Drugs Sales Market Share by Application (2017-2022)
Table 53. Europe Heart Failure Drugs Sales by Country (2017-2022) & (MT)
Table 54. Europe Heart Failure Drugs Sales Market Share by Country (2017-2022)
Table 55. Europe Heart Failure Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Heart Failure Drugs Revenue Market Share by Country (2017-2022)
Table 57. Europe Heart Failure Drugs Sales by Type (2017-2022) & (MT)
Table 58. Europe Heart Failure Drugs Sales Market Share by Type (2017-2022)
Table 59. Europe Heart Failure Drugs Sales by Application (2017-2022) & (MT)
Table 60. Europe Heart Failure Drugs Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Heart Failure Drugs Sales by Country (2017-2022) & (MT)
Table 62. Middle East & Africa Heart Failure Drugs Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Heart Failure Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Heart Failure Drugs Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Heart Failure Drugs Sales by Type (2017-2022) & (MT)
Table 66. Middle East & Africa Heart Failure Drugs Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Heart Failure Drugs Sales by Application (2017-2022) & (MT)
Table 68. Middle East & Africa Heart Failure Drugs Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Heart Failure Drugs
Table 70. Key Market Challenges & Risks of Heart Failure Drugs
Table 71. Key Industry Trends of Heart Failure Drugs
Table 72. Heart Failure Drugs Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Heart Failure Drugs Distributors List
Table 75. Heart Failure Drugs Customer List
Table 76. Global Heart Failure Drugs Sales Forecast by Region (2023-2028) & (MT)
Table 77. Global Heart Failure Drugs Sales Market Forecast by Region
Table 78. Global Heart Failure Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Heart Failure Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Heart Failure Drugs Sales Forecast by Country (2023-2028) & (MT)
Table 81. Americas Heart Failure Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Heart Failure Drugs Sales Forecast by Region (2023-2028) & (MT)
Table 83. APAC Heart Failure Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Heart Failure Drugs Sales Forecast by Country (2023-2028) & (MT)
Table 85. Europe Heart Failure Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Heart Failure Drugs Sales Forecast by Country (2023-2028) & (MT)
Table 87. Middle East & Africa Heart Failure Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Heart Failure Drugs Sales Forecast by Type (2023-2028) & (MT)
Table 89. Global Heart Failure Drugs Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Heart Failure Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Heart Failure Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Heart Failure Drugs Sales Forecast by Application (2023-2028) & (MT)
Table 93. Global Heart Failure Drugs Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Heart Failure Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Heart Failure Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 96. Novartis Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Novartis Heart Failure Drugs Product Offered
Table 98. Novartis Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 99. Novartis Main Business
Table 100. Novartis Latest Developments
Table 101. Pfizer Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. Pfizer Heart Failure Drugs Product Offered
Table 103. Pfizer Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 104. Pfizer Main Business
Table 105. Pfizer Latest Developments
Table 106. AstraZeneca Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. AstraZeneca Heart Failure Drugs Product Offered
Table 108. AstraZeneca Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 109. AstraZeneca Main Business
Table 110. AstraZeneca Latest Developments
Table 111. Hikma Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. Hikma Heart Failure Drugs Product Offered
Table 113. Hikma Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 114. Hikma Main Business
Table 115. Hikma Latest Developments
Table 116. Teva Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 117. Teva Heart Failure Drugs Product Offered
Table 118. Teva Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 119. Teva Main Business
Table 120. Teva Latest Developments
Table 121. Cipla Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 122. Cipla Heart Failure Drugs Product Offered
Table 123. Cipla Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 124. Cipla Main Business
Table 125. Cipla Latest Developments
Table 126. Merck & Co. Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 127. Merck & Co. Heart Failure Drugs Product Offered
Table 128. Merck & Co. Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 129. Merck & Co. Main Business
Table 130. Merck & Co. Latest Developments
Table 131. Amgen Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 132. Amgen Heart Failure Drugs Product Offered
Table 133. Amgen Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 134. Amgen Main Business
Table 135. Amgen Latest Developments
Table 136. Roche Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 137. Roche Heart Failure Drugs Product Offered
Table 138. Roche Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 139. Roche Main Business
Table 140. Roche Latest Developments
Table 141. Sun Pharma Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 142. Sun Pharma Heart Failure Drugs Product Offered
Table 143. Sun Pharma Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 144. Sun Pharma Main Business
Table 145. Sun Pharma Latest Developments
Table 146. Mylan Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors
Table 147. Mylan Heart Failure Drugs Product Offered
Table 148. Mylan Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 149. Mylan Main Business
Table 150. Mylan Latest Developments
List of Figures
Figure 1. Picture of Heart Failure Drugs
Figure 2. Heart Failure Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Heart Failure Drugs Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Heart Failure Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Heart Failure Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of ACEI
Figure 10. Product Picture of Angiotensin II Receptor Blockers
Figure 11. Product Picture of ARNIs
Figure 12. Product Picture of Beta Blockers
Figure 13. Product Picture of Aldosterone Antagonists
Figure 14. Product Picture of Diuretics
Figure 15. Global Heart Failure Drugs Sales Market Share by Type in 2021
Figure 16. Global Heart Failure Drugs Revenue Market Share by Type (2017-2022)
Figure 17. Heart Failure Drugs Consumed in Reduced Ejection Fraction
Figure 18. Global Heart Failure Drugs Market: Reduced Ejection Fraction (2017-2022) & (MT)
Figure 19. Heart Failure Drugs Consumed in Preserved Ejection Fraction
Figure 20. Global Heart Failure Drugs Market: Preserved Ejection Fraction (2017-2022) & (MT)
Figure 21. Global Heart Failure Drugs Sales Market Share by Application (2017-2022)
Figure 22. Global Heart Failure Drugs Revenue Market Share by Application in 2021
Figure 23. Heart Failure Drugs Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Heart Failure Drugs Revenue Market Share by Company in 2021
Figure 25. Global Heart Failure Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Heart Failure Drugs Revenue Market Share by Geographic Region in 2021
Figure 27. Global Heart Failure Drugs Sales Market Share by Region (2017-2022)
Figure 28. Global Heart Failure Drugs Revenue Market Share by Country/Region in 2021
Figure 29. Americas Heart Failure Drugs Sales 2017-2022 (MT)
Figure 30. Americas Heart Failure Drugs Revenue 2017-2022 ($ Millions)
Figure 31. APAC Heart Failure Drugs Sales 2017-2022 (MT)
Figure 32. APAC Heart Failure Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Europe Heart Failure Drugs Sales 2017-2022 (MT)
Figure 34. Europe Heart Failure Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Heart Failure Drugs Sales 2017-2022 (MT)
Figure 36. Middle East & Africa Heart Failure Drugs Revenue 2017-2022 ($ Millions)
Figure 37. Americas Heart Failure Drugs Sales Market Share by Country in 2021
Figure 38. Americas Heart Failure Drugs Revenue Market Share by Country in 2021
Figure 39. United States Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Heart Failure Drugs Sales Market Share by Region in 2021
Figure 44. APAC Heart Failure Drugs Revenue Market Share by Regions in 2021
Figure 45. China Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Heart Failure Drugs Sales Market Share by Country in 2021
Figure 52. Europe Heart Failure Drugs Revenue Market Share by Country in 2021
Figure 53. Germany Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Heart Failure Drugs Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Heart Failure Drugs Revenue Market Share by Country in 2021
Figure 60. Egypt Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Heart Failure Drugs in 2021
Figure 66. Manufacturing Process Analysis of Heart Failure Drugs
Figure 67. Industry Chain Structure of Heart Failure Drugs
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
